KLARU in the Globe - New Alzheimer's drug may slow or halt disease
Posted by Patricia Van Roon on 04/30/08
New Alzheimer's drug may slow or halt diseaseToday's Globe and Mail reports on the promising clinical trial results of a drug that could be among the first to slow or even halt the progression of Alzheimer's disease. Baycrest's Dr. Paul Verhoeff, Sam and Ida Ross Memory Clinic, offers his reaction to the news at the end of the story. Click on the link to read the full piece.
A drug in a potential new class of Alzheimer's medications showed promise in people with mild dementia, a new British and Canadian study suggests.If further studies, which are well under way, confirm those findings, the drug - tarenflurbil or Flurizan - could be among the first to slow or even halt progression of the mind-robbing disease, experts predict.
For more on this story, click here.